Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...
Shares of Philip Morris (NYSE:PM) snapped six straight sessions of gains, as the stock closed 0.74% down at $122.89 on ...
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United ...
FDA authorizes the marketing of 20 Zyn products because they pose fewer health risks than cigarettes and most smokeless products Shares of Philip Morris International Inc. extended their recent ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes WASHINGTON ...